Mark A. Bullimore, MCOptom, PhD, FAAO, FARVO

INDIANAPOLIS — To better manage patients with myopia, optometrists must understand normal myopia progression and axial elongation, as well as trends in treatment efficacy, according to a speaker at Academy 2024.

NEW ORLEANS — In this Healio Video Perspective from the ARVO meeting, Mark A. Bullimore, MCOptom, PhD, FAAO, discussed the use of atropine for myopia control in the LAMP study.

BOSTON – Study results presented here at the American Academy of Optometry annual meeting indicate that 300 million people around the world will be visually impaired – classified as 20/40 or worse vision – in 2050.

Mark A. Bullimore, MCOptom, PhD, FAAO, FARVO, presented a poster at this year’s ARVO virtual meeting focused on the link between growing rates of myopia and projected visual impairment in the U.S.